(Q53099009)

11 May 2018

title

Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma. (English)

1 reference

11 May 2018

adaptive radiation therapy

main subject

0 references

author

Naoko Sanuki

2

1 reference

11 May 2018

author name string

Atsuya Takeda

1

1 reference

11 May 2018

Takahisa Eriguchi

3

1 reference

11 May 2018

Takashi Kobayashi

4

1 reference

11 May 2018

Shogo Iwabutchi

5

1 reference

11 May 2018

Kotaro Matsunaga

6

1 reference

11 May 2018

Tomikazu Mizuno

7

1 reference

11 May 2018

Kae Yashiro

8

1 reference

11 May 2018

Shuichi Nisimura

9

1 reference

11 May 2018

Etsuo Kunieda

10

1 reference

11 May 2018

publication date

1 February 2014

1 reference

11 May 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

11 May 2018

volume

29

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

372-379

1 reference

11 May 2018

Management of hepatocellular carcinoma: An update

cites work

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 January 2018

1 reference

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites

21 January 2018

1 reference

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications

21 January 2018

1 reference

Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.

21 January 2018

1 reference

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

21 January 2018

1 reference

Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.

21 January 2018

1 reference

Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy--initial findings.

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

21 January 2018

1 reference

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

21 January 2018

1 reference

Current strategy for staging and treatment: the BCLC update and future prospects.

21 January 2018

1 reference

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

21 January 2018

1 reference

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system

21 January 2018

1 reference

Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies.

21 January 2018

1 reference

Radiation-associated liver injury.

21 January 2018

1 reference

Report of the 18th follow-up survey of primary liver cancer in Japan

21 January 2018

1 reference

Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12350

1 reference

11 May 2018

1 reference

11 May 2018